News

Issued by Kaplan Fox & Kilsheimer LLP, not Quantum Biopharma Ltd. Subordinate Voting Shares Class B

QNTM DEADLINE: Investors of Quantum Biopharma Ltd. (QNTM) are Encouraged to Contact Kaplan Fox Before the Lead Plaintiff Deadline on February 23, 2026

January 7, 2026

It isn’t one of Quantum Biopharma Ltd. Subordinate Voting Shares Class B’s news releases, so 6ix doesn’t show it on Quantum Biopharma Ltd. Subordinate Voting Shares Class B’s page or send it as an alert.

Go to Quantum Biopharma Ltd. Subordinate Voting Shares Class B on 6ix